← SynDRA
VOGLIBOSE
SynDRA canonical compound SYN0016300 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | GAA | MGAM |
|---|
| Mechanism of action | glucosidase inhibitor |
|---|
| Indication | diabetes mellitus | hyperglycemia |
|---|
| Disease area | endocrinology |
|---|
All known targets
- MGAM
- GAA
- AGL
- Gaa
- MGAM2
- SI
- Si
Mechanisms of action (all sources)
- MGAM INHIBITOR
- Alpha glucosidase inhibitor
- GAA INHIBITOR
- SI INHIBITOR
- MGAM2 INHIBITOR
- glucosidase inhibitor
Drug classes
- Enzyme Inhibitors
- Glycoside Hydrolase Inhibitors
- Hypoglycemic Agents
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- glustat
- voglistat
- AO-128
- Voglibosa
- A-71100
- Basen
- Glustat
- Vocarb
- Basen OD
- Basen (TN)
- Basen (Takeda Chemical Industries)
- Volix (Ranbaxy labs);Voglibose (JP15/USAN/INN)
- N-(1,3-Dihydroxyprop-2-yl)valiolamine
- (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol
- (1S,2S,3R,4S,5S)-5-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino}-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol
- 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol
- AO 128
- Voglibosum
- A 71100
- N-(1,3-Dihydroxy-2-propyl)valiolamine
- S77P977AG8
- DTXCID901442
- RefChem:902044
- A10BF03
- MFCD00865496
- C10H21NO7
- Voglibose [INN]
- CAS-83480-29-9
- Voglibose [USAN:INN]
- Voglibosum [INN-Latin]
- Voglibosa [INN-Spanish]
- UNII-S77P977AG8
- CCRIS 4540
- NCGC00164595-01
- VOG
- Voglibose Impurity 34
- VOGLIBOSE [JAN]
- VOGLIBOSE [MI]
Look up VOGLIBOSE in the interactive SynDRA portal →